Author

Daniel McCormick

Observed institutions: Naval Surface Warfare Center, NSWC Crane Division

OpenAlex ID: A5123034769

First-in-human phase 1/2 study of ETX-19477, an oral, potent, and selective PARG inhibitor, in patients with advanced solid tumors (ERADIC8).

2026 · Ezra Rosen, Pooja Prem Advani, et al. · Journal of Clinical Oncology · 1

A Comprehensive Approach to Ensuring Reliability in Ultra HDI Solutions

2024 · Daniel McCormick · Specialized and Legacy Electronics Manufacturing Conferences

Works count: 2

Citation count: 1

H-index: 1

I10-index: